EYEN - MCAP CO - Eyenovia, Inc.

This chart of Eyenovia, Inc. (EYEN) asset value on the GURU.Markets platform, which currently stands at , demonstrates the position of the developer of Optejet contactless drug delivery. The company is fighting for market share and defending its patents against industry behemoths amid a capital shortage. Business stability relies on the streamlined transportation of high-tech equipment and reagents to specialized centers.

Investors seek an optimal balance between asset quality and current pricing. The total value of all shares reflects the market valuation of the business relative to its history. For Eyenovia, Inc. (EYEN), this metric is critical, as the early stage of smart applicator implementation and high unit costs limit current margins. Analyzing the company's value via market capitalization allows for the determination of the issuer's degree of undervaluation prior to scaling sales.